Jeff W Terryberry

Title: Jeff W. Terryberry: Innovator in Glycosylation Detection

Introduction

Jeff W. Terryberry, based in Santa Monica, California, is an accomplished inventor with a focus on advancing the field of metabolic disorder diagnostics. He holds a patent that revolutionizes the detection of glycosylation deficiency disorders, showcasing his contribution to medical research and innovation.

Latest Patents

Jeff W. Terryberry's patent, titled "Assay for Glycosylation Deficiency Disorders," provides a method for detecting carbohydrate-deficient glycoproteins in samples from subjects with metabolic disorders, including alcohol abuse. The patented method includes reglycosylating deglycosylated glycoproteins using a fluorescent conjugate in body fluid samples. It also employs fluorometric detection of fluoresceinylated carbohydrates, enhancing the ability to identify abnormal levels of carbohydrate-deficient glycoproteins, which is crucial for diagnosing these disorders.

Career Highlights

Terryberry works at Specialty Laboratories, Inc., where he applies his expertise to develop diagnostic tools that aid in the understanding and treatment of metabolic disorders. His contribution to the field not only enhances diagnostic capabilities but also improves patient outcomes by facilitating earlier and more accurate diagnosis.

Collaborations

In his professional journey, Jeff works alongside talented individuals such as Pamela Bean. Collaborating with skilled professionals has allowed him to share knowledge and drive innovation in the healthcare and diagnostics industry together.

Conclusion

With his dedication to innovation and significant contributions to medical diagnostics, Jeff W. Terryberry stands out as an influential figure in the realm of glycosylation deficiency disorders. His patent demonstrates the impact of scientific advancements on healthcare, marking him as an inventor whose work continues to influence the field.